CRL vs HUM · rev $2.00B vs P/E 39, rev $129.66B
Charles River Laboratories (CRL) versus Humana Inc (HUM) — a side-by-side from cached financials, not a winner call.
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
Latest reported CRL revenue for 2026-06-27 was $2.00B. Net income was -$16.3M. CRL currently screens at market cap $7.78B.
Latest reported HUM revenue for 2025-12-31 was $129.66B. Net income was $1.19B. Revenue was up 10.1% from 2024-12-31 to 2025-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
CRL currently screens at market cap $7.78B. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
Not investment advice. Open the CRL and HUM stock pages for the full models.
Not investment advice.